Literature DB >> 20556415

Early stent thrombosis with progressive brainstem infarction in a clopidogrel non-responder.

Jens Weise, Mike Reinhöfer, Otto W Witte, Thomas E Mayer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20556415     DOI： 10.1007/s00415-010-5587-3

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  8 in total

1.  Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation.

Authors:  Tobias Geisler; Harald Langer; Magdalena Wydymus; Katrin Göhring; Christine Zürn; Boris Bigalke; Konstantinos Stellos; Andreas E May; Meinrad Gawaz
Journal:  Eur Heart J       Date:  2006-09-27       Impact factor: 29.983

2.  Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease.

Authors:  Tomas Jernberg; Christopher D Payne; Kenneth J Winters; Christelle Darstein; John T Brandt; Joseph A Jakubowski; Hideo Naganuma; Agneta Siegbahn; Lars Wallentin
Journal:  Eur Heart J       Date:  2006-04-18       Impact factor: 29.983

Review 3.  Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials.

Authors:  Michelle L O'Donoghue; Eugene Braunwald; Elliott M Antman; Sabina A Murphy; Eric R Bates; Yoseph Rozenman; Alan D Michelson; Raymond W Hautvast; Peter N Ver Lee; Sandra L Close; Lei Shen; Jessica L Mega; Marc S Sabatine; Stephen D Wiviott
Journal:  Lancet       Date:  2009-08-31       Impact factor: 79.321

4.  Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study.

Authors:  Martine Gilard; Bertrand Arnaud; Jean-Christophe Cornily; Grégoire Le Gal; Karine Lacut; Geneviève Le Calvez; Jacques Mansourati; Dominique Mottier; Jean-François Abgrall; Jacques Boschat
Journal:  J Am Coll Cardiol       Date:  2008-01-22       Impact factor: 24.094

5.  Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel.

Authors:  Jolanta M Siller-Matula; Alexander O Spiel; Irene M Lang; Gerhard Kreiner; Guenter Christ; Bernd Jilma
Journal:  Am Heart J       Date:  2008-11-06       Impact factor: 4.749

6.  Genetic determinants of response to clopidogrel and cardiovascular events.

Authors:  Tabassome Simon; Céline Verstuyft; Murielle Mary-Krause; Lina Quteineh; Elodie Drouet; Nicolas Méneveau; P Gabriel Steg; Jean Ferrières; Nicolas Danchin; Laurent Becquemont
Journal:  N Engl J Med       Date:  2008-12-22       Impact factor: 91.245

7.  Monitoring of clopidogrel-related platelet inhibition: correlation of nonresponse with clinical outcome in supra-aortic stenting.

Authors:  S Müller-Schunk; J Linn; N Peters; M Spannagl; M Deisenberg; H Brückmann; T E Mayer
Journal:  AJNR Am J Neuroradiol       Date:  2008-01-25       Impact factor: 3.825

8.  Clopidogrel 150 mg/day to overcome low responsiveness in patients undergoing elective percutaneous coronary intervention: results from the VASP-02 (Vasodilator-Stimulated Phosphoprotein-02) randomized study.

Authors:  Boris Aleil; Laurent Jacquemin; Fabien De Poli; Michel Zaehringer; Jean-Philippe Collet; Gilles Montalescot; Jean-Pierre Cazenave; Marie-Claude Dickele; Jean-Pierre Monassier; Christian Gachet
Journal:  JACC Cardiovasc Interv       Date:  2008-12       Impact factor: 11.195
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.